By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Wealth Beat NewsWealth Beat News
  • Home
  • News
  • Finance
  • Investing
  • Banks
  • Mortgage
  • Loans
  • Credit Cards
  • Small Business
  • Dept Management
Notification Show More
Aa
Wealth Beat NewsWealth Beat News
Aa
  • News
  • Finance
  • Investing
  • Banks
  • Mortgage
  • Loans
  • Credit Cards
  • Small Business
  • Dept Management
Follow US
Wealth Beat News > News > GeneDx: Strong Fundamentals Intact As Market Misreads Test Volume Dip
News

GeneDx: Strong Fundamentals Intact As Market Misreads Test Volume Dip

News
Last updated: 2025/05/20 at 9:41 AM
By News
Share
4 Min Read
SHARE

This article was written by

I have gained extensive experience as an Analyst, working in both Buy (Asset Management) and Sell (Investment Brokerage) side roles, as well as holding positions in Strategy and Finance within the technology services sector. Over the years, I have focused on publishing quantitative model portfolios that prioritize risk-adjusted returns.

Currently, we offer three distinct model portfolio services: Prudent Healthcare, which is exclusively available on Seeking Alpha marketplace, Prudent Biotech and Prudent Small Cap. On the respective pages of these services, you have an opportunity to register for a Free Monthly Pick from these model portfolios.

In partnership with Seeking Alpha, we are proud to present the Prudent Healthcare model portfolio, exclusively accessible through the SA Marketplace. This monthly service has consistently demonstrated a strong and leading performance record in the healthcare sector.

If you have any questions, please feel free to contact us.

Analyst’s Disclosure: I/we have a beneficial long position in the shares of WGS either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

SOME STOCKS MENTIONED CAN ALREADY BE PART OF THE PORTFOLIOS OF FAMILY AND ASSOCIATES and retirement accounts like IRAs, and can be bought/sold in the next 72 hours. The stocks mentioned may already be part of the Prudent Biotech, Prudent Healthcare, or Prudent Small Cap model portfolios. As always, kindly do your due diligence. Small caps and biotechs carry a higher risk of losses than the broader market. Opinions can change with time and additional data, with no obligation to update. Companies mentioned here may not be favored in the future as market trends change and/or new information emerges, and no relevant portfolio updates will be provided unless you are a model portfolio subscriber. PrudentBiotech.com, PrudentHealthcare.com, PrudentSmallCap.com, Graycell Advisors, or any other associated names and entities are not registered investment advisors (RIAs) and publish quantitative-driven model portfolios for investors and RIAs. Stocks mentioned in the article may be in the past, present, or future and be part of the various model portfolios for subscribers. Past performance is not a guarantee of future results. The information here is only provided for a general informational purpose and not as a recommendation and is not guaranteed to be complete or accurate.

Seeking Alpha’s Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Read the full article here

News May 20, 2025 May 20, 2025
Share this Article
Facebook Twitter Copy Link Print
Leave a comment Leave a comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Fast Four Quiz: Precision Medicine in Cancer

How much do you know about precision medicine in cancer? Test your knowledge with this quick quiz.
Get Started
Excelerate Energy: Nearby Best Energy-Source Cap-Gain Prospect (NYSE:EE)

The primary focus of this article is Excelerate Energy, Inc. (NYSE:EE). Investment…

Penske Is Steady, But The Road Ahead May Be Bumpy (NYSE:PAG)

Investing Thesis On Wednesday, Penske Automotive Group (NYSE:PAG) released a superficially encouraging…

Top Financial – No, Stop It, This Is Silly (NASDAQ:TOP)

TOP Financial Moves, yes, but why? TOP Financial (NASDAQ:TOP) was quite the…

You Might Also Like

News

Palo Alto Networks, Inc. 2025 Q3 – Results – Earnings Call Presentation (NASDAQ:PANW)

By News
News

69 May Aristocrats: Buy 1 Of 38 “Safer” Dividend Dogs

By News
News

NET Power: A Capitalized Pre-Revenue Company Investors Still Don’t Trust (NYSE:NPWR)

By News
News

Eagle Materials Inc. 2025 Q4 – Results – Earnings Call Presentation (NYSE:EXP)

By News
Facebook Twitter Pinterest Youtube Instagram
Company
  • Privacy Policy
  • Terms & Conditions
  • Contact US
More Info
  • Newsletter
  • Finance
  • Investing
  • Small Business
  • Dept Management

Sign Up For Free

Subscribe to our newsletter and don't miss out on our programs, webinars and trainings.

I have read and agree to the terms & conditions

Join Community

2025 © wealthbeatnews.com. All Rights Reserved.

Join Us!

Subscribe to our newsletter and never miss our latest news, podcasts etc.

I have read and agree to the terms & conditions
Zero spam, Unsubscribe at any time.
Welcome Back!

Sign in to your account

Lost your password?